Showing results (131-140 of 226) with videos related to
Sort By:
Pageof 23
Npj Aging|February 10, 2026
Frailty phenotype reveals heterogeneity in aging and distinct taurine associationsApril Kim, Rebecca Keener, Ashton Omdahl, et al.Journal of Psychopharmacology (Oxford, England)|November 30, 2018
Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamineJaclyn N Highland, Patrick J Morris, Panos Zanos, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2021
Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cellsJonna Tenhunen, Tomáš Kučera, Marjo Huovinen, et al.Journal of Pharmaceutical and Biomedical Analysis|March 10, 2021
The synthesis and characterization of Bri2 BRICHOS coated magnetic particles and their application to protein fishing: Identification of novel binding proteinsHelene Tigro, Nina Kronqvist, Axel Abelein, et al.The Journal of Clinical Endocrinology and Metabolism|June 28, 2018
Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older AdultsRichard D Semba, Marta Gonzalez-Freire, Ruin Moaddel, et al.Elife|October 24, 2019
Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondriaCeereena Ubaida-Mohien, Alexey Lyashkov, Marta Gonzalez-Freire, et al.Journal of Alzheimer'S Disease : JAD|April 25, 2022
Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in HumansChristopher E Ramsden, Gregory S Keyes, Elizabeth Calzada, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2020
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another PandemicKarl Kieburtz, Russell Katz, Andrew McGarry, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2011
Pharmacologic approaches to the treatment of Huntington's diseaseCharles S Venuto, Andrew McGarry, Qing Ma, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2012
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyLobna Ibrahim, Nancy Diazgranados, Jose Franco-Chaves, et al.Pageof 23